Life Sciences News in Northern California - June 2009
 
 

Healthcare Reform Legislation Coming Into Focus

After months of behind the scenes negotiations, healthcare reform efforts in Washington DC are starting to come into focus. While legislation has yet to be formally introduced, the President and congressional leaders have been working with stakeholders since January.

While most legislators agree on the need for reform that increases access, maintains quality and lowers costs, how that goal should be accomplished and paid for remains very contentious. The most controversial proposals includes the creation of a public option that would allow individuals to buy into a government run healthcare plan, and include a pathway for approval of follow-on biologics. Both proposals could have potentially unintended consequences on California’s life sciences research and development.

BioEconomy Summit

MDMA's Washington Update

Senate Confirms Sebelius and Hamburg

The Senate confirmed Kathleen Sebelius as Secretary of Health and Human Services. Ms. Sebelius was confirmed by a final vote of 65-31, with eight Republicans voting for her confirmation. She now takes control of the Agency as Congress and the President begin their efforts for broad-based health care reform.

The Senate also confirmed Dr. Margaret Hamburg as the 21st Commissioner of the Food and Drug Administration. Dr. Hamburg replaces Acting Commissioner Josh Sharfstein, who will now take the role of Deputy Commissioner. Hamburg received widespread support in the Senate and was approved by voice vote.

Medical Device Breakfast Series

M&A: Prepare to speed date

Tips to improve your M&A readiness

By Mike Rose

For many emerging biotech companies, there’s no place to go but mergers and acquisitions (M&A) for funding. And, for the M&A courting process, there are many simple, yet often overlooked, finance and accounting items that target firms commonly overlook that can help bring resolution.

I think of these basic steps as being “M&A ready,” and they are the way to go for any young enterprise looking to do a deal. They help speed up the dating process and are something along the lines of today’s speed dating concept for busy professional singles.

 
The Risks of Betting Wrong
By Matthew M. Gardner

President The upside of the public discussion over the American Recovery and Reinvestment Act (ARRA) is that the President’s pledge of transparency is being played out faithfully at the State and Federal levels. The downside – to those in the business of innovation – is that the wisdom of the bets being placed can be so quickly second-guessed.

These bets being placed are plainly visible in California. To their credit, the State has published a map of projects funded by the stimulus package. What is disproportionately clear at first and extended glance, however, is that the State’s top priority is overwhelmingly transportation.

Follow us on Facebook
Follow us on Twitter
Follow us on Twitter
Top five articles selected by
Elsevier Business Intelligence readers
over the last month
Results based on number of times each story was clicked by readers.
BayBio Institute

What Pipeline? Giving Back and Boosting Morale in Uncertain Economic Times

The strains of the current economy have forced many companies to scale back engagement in a number of educational partnerships. Immediate bottom line concerns have overwhelmed a long-term vision of the workforce pipeline, with fewer staff and projects available to emerging (student) scientists.

Add to this the growing pool of unemployed science workers, and it is not difficult to understand the diminished role of the industry in local education and workforce development initiatives.

Increasingly over the past two decades, Northern California life science educators and county workforce boards have been working together to address the demand for qualified workers in the Bay Area’s booming bioscience sector. The region has taken the lead in the development of a number of innovative industry/education collaborative training programs, replete with mutual benefits such as customized curriculum, equipment donations, and on-the-job training and internship opportunities.

BayBio Partners
ABD Insurance Pioneering Science Delivers Vital Medicines BioSpace BPM Burrill & Company - A Life Sciences Merchant Bank Cooley Godward Kronish Gray Cary Deloitte Touche Tohmatsu
Ernst & Young FedEx Fenwick & West LLP - Lawyers who get IT Genencor Genentech- In Business for Life Gilead- Advancing Therapeutics, Improving Lives Invitrogen
KPMG Latham Morrison & Foerster Nektar Therapuetics Oracle - Applications for Life Sciences Pfizer - Working Together for a Healthier World Roche - We Innovate Healthcare
RoseRyan: Relax. You Just Added Fifty Senior Finance Gurus to Your Team. Schwartz Communications Technology Vision Group LL - Innovation Is At The Heart of Who We Are VWR - Supplier Partnerships for Customer Solutions Wareham - Visionary. Innovative. Dynamic. Responsive Wells Fargo  
         
  BayBio
395 Oyster Point Blvd. #117
South San Francisco, CA 94080
Tel: 650-871-7101
Fax: 650-871-7555
www.baybio.org
East Bay Office
5858 Horton Street
Suite 453
Emeryville, CA 94608
Tel: 510-450-0901
Sacramento Office
400 West Capitol Mall
11th Floor
Sacramento, CA 95814
Tel: 916-558-6109